Published in Pharma Law Weekly, December 14th, 2004
The purchase includes five letters of patent, together with several foreign patents and/or patents pending and other assets of FHJ.
FHJ is a privately held Texas corporation, which was formed in 1985. FHJ has the proprietary SHBAN Solution. In vitro and other testing have, according to the company, demonstrated the capabilities and superiority of SHBAN over known commercial products in applications covering contact dermatitis, dermal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly